Europe Orders 100 Million Additional COVID-19 Vaccines

Germany based BioNTech SE and Pfizer, Inc. announced they would supply an additional 100 million doses of Comirnaty, the companies’ mRNA based COVID-19 Vaccine, to the 27 European Union (EU) member states in 2021. This agreement brings the total number of Comirnaty vaccine doses to the EU to 300 million.

Comirnaty will be produced in BioNTech’s and Pfizer’s manufacturing sites in Europe. The vaccine's distribution by the EU member states will continue to be determined according to the populations identified in EU, and national guidance said BioNTech on December 29, 2020.

The Pfizer-BioNTech developed COVID-19 Vaccine has been granted conditional marketing authorization by the European Medicines Agency to prevent COVID-19 in people from 16 years of age.

"Our goal remains to bring a safe and effective COVID-19 vaccine to as many people as we can all around the world,” commented Ugur Sahin, M.D., CEO and Co-founder of BioNTech.